C
NAUT icon

Covestor’s Nautilus Biotechnolgy NAUT Stock Holding History

Covestor’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
8
– – ﹤0.01% 2717
2026
Q1 		$0 Hold
8
– – ﹤0.01% 2596
2025
Q4 		$0 Hold
8
– – ﹤0.01% 2571
2025
Q3 		$0 Hold
8
– – ﹤0.01% 2584
2025
Q2 		$0 Hold
8
– – ﹤0.01% 2552
2025
Q1 		$0 Hold
8
– – ﹤0.01% 2545
2024
Q4 		$0 Buy
8
+1
+14% +$2 ﹤0.01% 2554
2024
Q3 		$0 Hold
7
– – ﹤0.01% 2549
2024
Q2 		$0 Hold
7
– – ﹤0.01% 2564
2024
Q1 		$0 Hold
7
– – ﹤0.01% 2557
2023
Q4 		$0 Buy
7
+2
+40% +$6 ﹤0.01% 2501
2023
Q3 		$0 Hold
5
– – ﹤0.01% 2484
2023
Q2 		$0 Buy
+5
New +$14 ﹤0.01% 2461

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Covestor's NAUT Position: Q2 2026 in Review

Covestor held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2717.

Covestor first reported a position in NAUT in Q2 2023 and has held it in 13 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Covestor held 8 shares of Nautilus Biotechnolgy worth $0 as of Q2 2026.
  • Covestor left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2717 holding.
  • Covestor first reported a position in Nautilus Biotechnolgy in Q2 2023 and has held it in 13 quarters since.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.